Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts

References

• NojiEKThe global resurgence of infectious diseasesTrend Report20019223232
   Google Scholar
• PayneDSpread of chloroquine resistance in Plasmodium falciparumParasitol Today1987324124615462966
   PubMedGoogle Scholar
• WhiteNJQinghaosu (artemisinin): the price of successScience200832033033418420924
   PubMed Web of Science ®Google Scholar
• ter KuileFWhiteNJHolowayPPasvolGKrishnaSPlasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malariaExp Parasitol19937685958467901
   PubMed Web of Science ®Google Scholar
• ChenPQLiGQGuoXBThe infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisininsChin Med J. (Engl.)19941077097117805466
   PubMed Web of Science ®Google Scholar
• WhiteNJOlliaroPArtemisinin and derivatives in the treatment of uncomplicated malariaMed Trop1998585456
   PubMedGoogle Scholar
• PeterWSession 2: global perspectives of malaria changing pattern of antimalarial drug resistanceJ Royal Soc MedicineSupp 171989821316
   Google Scholar
• Eckstein-LudwigUWebbRvan GoethamDAArtemisinins target the SERCA of Plasmodium falciparumNature200342495796112931192
   PubMed Web of Science ®Google Scholar
• JambouRLegrandENiangMResistance of Plasmodium falciparum field isolates to in vitro artemether and point mutations of the SERCA-type PfATPase6Lancet20053661960196316325698
   PubMed Web of Science ®Google Scholar
• GreenhouseBSlaterMNjama-MeyaDDecreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistanceJ Infect Dis200919975876519199542
   PubMed Web of Science ®Google Scholar
• EnevoldANkyaWMTheisenMPotential impact of host immunity of malaria treatment outcome in Tanzanian children infected with Plasmodium falciparumMalar J2007615316218021388
   PubMed Web of Science ®Google Scholar
• DondorpAMNostenFYiPArtemisinin resistance in Plasmodium falciparum malariaN Engl J Med200936145567 Erratum in: N Engl J Med. 2009;361:171419641202
   PubMed Web of Science ®Google Scholar
• SchönfeldMBarretoMISchunkMMolecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west TanzaniaMalar J20071562
   Google Scholar
• MboeraLEMakundiEAKituaAYUncertainty in malaria control in Tanzania: crossroads and challenges for future interventionsAm J Trop Med Hyg20077711211818165482
   PubMed Web of Science ®Google Scholar
• MulliganJAMandikeRPalmerNThe costs of changing national policy: lessons from malaria treatment policy guidelines in TanzaniaTrop Med Int Health20061145246116553928
   PubMed Web of Science ®Google Scholar
• MulliganJAMandikeRPalmerNThe costs of changing national policy: lessons from malaria treatment policy guidelines in TanzaniaTrop Med Int Health20061145246116553928
   PubMed Web of Science ®Google Scholar
• ShrettaROmumboJRapuodaBASnowRWUsing evidence to change antimalarial drug policy in KenyaTrop Med Int Health2000575576411123822
   PubMed Web of Science ®Google Scholar
• KamyaMRBakyaitaNNTalisunaAOWereWMStaedkeSGIncreasing antimalarial drug resistance in Uganda and revision of the national drug policyTrop Med Int Health200271031104112460394
   PubMed Web of Science ®Google Scholar
• KindermansJMPecoulBPerez-CasasCBoerMDBermanDCoxIChanging national malaria treatment protocols in Africa: what is the cost and who will pay? Case studies: Burundi, Kenya, Rwanda, Tanzania and UgandaMedicins Sans Frontieres2002115
   Google Scholar
• WilliamsHADurrheimDNShrettaRThe process of changing national malaria treatment policy: lessons from country-level studiesHealth Policy Plan20041935637015459161
   PubMed Web of Science ®Google Scholar
• MulliganJAMandikeRPalmerNThe costs of changing national policy: lessons from malaria treatment policy guidelines in TanzaniaTrop Med Int Health20061145246116553928
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAccess to antimalarial medicines: improving the affordability and financing of artemisinin-based combination therapiesGeneva, SwitzerlandWHO2003115
   Google Scholar
• AminAAZurovacDKangwanaBBThe challenges of changing national malaria drug policy to artemisinin-based combinations in KenyaMalar J200767217535417
   PubMed Web of Science ®Google Scholar
• WilliamsHADurrheimDShrettaRThe process of changing national malaria treatment policy: lessons from country-level studiesHealth Pol Plan200419356370
   PubMed Web of Science ®Google Scholar
• World Health OrganizationSusceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring: 1996–2004WHO, Geneva
   Google Scholar
• World Health OrganizationFacts on ACTs (Artemisin-based Combination Therapies), January 2006 update2006 Available from: http://www.rollbackmalaria.org/cmc_upload/0/000/015/364/RBMInfosheet_9.htm. Accessed Jul 20, 2010.
   Google Scholar
• World Health OrganizationA global strategy for malaria controlGeneva, SwitzerlandWHO1993
   Google Scholar
• World Health OrganizationWorld malaria report 2009Geneva, SwitzerlandWHO2009
   Google Scholar
• AshtonMNguyenDSNguyenVHArtemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malariaClin Pharmacol Ther1998634824939585803
   PubMed Web of Science ®Google Scholar
• AsimusSElsherbinyDHaiTNArtemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjectsFundam Clin Pharmacol20072130731617521300
   PubMed Web of Science ®Google Scholar
• World Health OrganizationThe treatment of malariaGeneva, SwitzerlandWHO2006
   Google Scholar
• DondorpAMNostenFPoravuthDReduced in-vivo susceptibility of Plasmodium falciparum to artesunate in Western CambodiaN Engl J Med [In press.]
   Google Scholar
• SamarasekeraUCountries race to contain resistance to key antimalarialLancet200937427728019639670
   PubMed Web of Science ®Google Scholar
• World Health OrganizationWorld malaria report 2005Geneva, SwitzerlandWHO2005
   Google Scholar
• FofanaBDijimdeAASagaraIImpact of artemisinin-based combination therapy on malaria transmission in Mali2009 (MIM16762172 www.minmalaria.org)
   Google Scholar
• WhiteNNostenFLooareesuwanSAverting a malaria disasterLancet19993531965196710371589
   PubMed Web of Science ®Google Scholar
• DondorpAMYeungSWhiteLArtemisinin resistance: current status and scenarios for containmentNat Rev Microbiol2010827228020208550
   PubMed Web of Science ®Google Scholar
• MaudeRJPontavornpinyoWSaralambaSThe last man standing is the most resistant: eliminating artemisinin-resistant malaria in CambodiaMalar J200983119228438
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal malaria control and elimination: report of a meeting on containment of artemisinin toleranceGeneva, SwitzerlandWHO2008
   Google Scholar
• GallupJLSachsJDThe economic burden of malariaAm J Trop Med Hyg200164859611425181
   PubMed Web of Science ®Google Scholar
• MboeraLEMakundiEAKituaAYUncertainty in malaria control in Tanzania: crossroads and challenges for future interventionsAm J Trop Med Hyg20077711211818165482
   PubMed Web of Science ®Google Scholar
• SayangCGausseresMVernazza-LichtNMalvyDBleyDMilletPTreatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, CameroonMalar J20092817619640292
   PubMed Web of Science ®Google Scholar
• SayangCGausseresMVernazza-LichtNMalvyDBleyDMilletPTreatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, CameroonMalar J2009817619640292
   PubMed Web of Science ®Google Scholar
• LaxminarayanRACT Now or later: the economics of malaria resistance. Resources for the future2003 Discussion Paper. 3–51
   Google Scholar
• BjorkmanABhattaraiAPublic health impact of drug resistant Plasmodium falciparum malariaActa Trop20059416316915893289
   PubMed Web of Science ®Google Scholar
• PanosianCEconomic access to effective drugs for falciparum malariaClin Infect Dis20054071371715714418
   PubMed Web of Science ®Google Scholar